Chronic Respiratory Disease

Respiratory therapists ranked third on the top five list of most in-demand health care jobs of 2024, according to research conducted by Soliant Health.

SAN FRANCISCO — The availability and pricing of asthma and COPD medications varies across different settings, with greater availability in urban and higher-income settings compared with rural and lower-income settings, researchers reported.

Male sex, elevated baseline body temperature and increased respiratory rate were COVID-19 risk factors among ambulatory patients with chronic respiratory disease and acute respiratory symptoms, researchers reported in Respiratory Medicine.

High anxiety during the COVID-19 pandemic is a potential risk factor for clinical worsening of severe asthma and decline in quality of life, researchers reported.

In a new study, automated voice and breath analysis was associated with good predictive accuracy of FVC and FEV1 and classification of obstructed vs. nonobstructed lung disease.

Home-based telerehabilitation demonstrated improved quality of life but was not confirmed to be equivalent to center-based pulmonary rehabilitation, researchers reported at the virtual European Respiratory Society International Congress.

The FDA has approved triple inhaled therapy for maintenance treatment of patients with COPD, according to a press release from AstraZeneca.

A study recently published in The BMJ suggests that the number of total deaths worldwide due to chronic respiratory diseases has increased during the past 3 decades, although age-standardized mortality rates have generally declined.